Actively Recruiting

Phase 3
Age: 18Years - 85Years
All Genders
NCT07288398

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Led by Tenax Therapeutics, Inc. · Updated on 2026-03-16

540

Participants Needed

92

Research Sites

173 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with preserved left ventricular ejection fraction (PH-HFpEF) as measured by the change in 6-Minute Walk Distance.

CONDITIONS

Official Title

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men or women aged 18 to 85 years
  • New York Heart Association (NYHA) Class II or III symptoms, or ambulatory Class IV symptoms
  • Diagnosed with WHO Group 2 pulmonary hypertension with preserved left ventricular ejection fraction
  • Qualifying measurements from right heart catheterization and echocardiogram
  • Qualifying 6-minute walk distance test
  • 48-hour ambulatory heart rhythm monitoring during screening
  • Compliance with childbearing potential, contraception, and egg/sperm donation requirements
Not Eligible

You will not qualify if you...

  • Diagnosis of pulmonary hypertension WHO Groups 1, 3, 4, or 5
  • Evidence of hypertrophic, restrictive, infiltrative cardiomyopathy, constrictive pericarditis, or cardiac amyloidosis
  • Prior or planned valve repair or replacement, or significant valve disease
  • Pre-existing lung disease
  • History of severe allergic or anaphylactic reaction to study drug components
  • Major surgery within 60 days before study
  • Prior heart, lung, or combined transplants or life expectancy under 12 months
  • Other serious diseases limiting study participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 92 locations

1

Tenax Investigational Site

Alexander City, Alabama, United States, 35010

Actively Recruiting

2

Tenax Investigational Site

Tamarac, Florida, United States, 33321

Not Yet Recruiting

3

Tenax Investigational Site

Mount Prospect, Illinois, United States, 60056

Not Yet Recruiting

4

Tenax Investigational Site

Peoria, Illinois, United States, 61636

Actively Recruiting

5

Tenax Investigational Site

New Orleans, Louisiana, United States, 70115-6969

Actively Recruiting

6

Tenax Investigational Site

West Monroe, Louisiana, United States, 71291

Actively Recruiting

7

Tenax Investigational Site

Ypsilanti, Michigan, United States, 48197

Not Yet Recruiting

8

Tenax Investigational Site

Reno, Nevada, United States, 89502

Actively Recruiting

9

Tenax Investigational Site

New York, New York, United States, 10032

Not Yet Recruiting

10

Tenax Investigational Site

Winston-Salem, North Carolina, United States, 27101

Actively Recruiting

11

Tenax Investigational Site

Allentown, Pennsylvania, United States, 18105

Not Yet Recruiting

12

Tenax Investigational Site

Wynnewood, Pennsylvania, United States, 19096-3450

Not Yet Recruiting

13

Tenax Investigational Site

Nashville, Tennessee, United States, 37205

Actively Recruiting

14

Tenax Investigational Site

Austin, Texas, United States, 78705

Actively Recruiting

15

Tenax Investigational Site

Dallas, Texas, United States, 75390

Actively Recruiting

16

Tenax Investigational Site

Houston, Texas, United States, 77002

Actively Recruiting

17

Tenax Investigational Site

Norfolk, Virginia, United States, 23507-1904

Not Yet Recruiting

18

Tenax Investigational Site

Marshfield, Wisconsin, United States, 54449

Not Yet Recruiting

19

Tenax Investigational Site

Buenos Aires, Buenos Aires F.D., Argentina, 1280

Not Yet Recruiting

20

Tenax Investigational Site

Corrientes, Corrientes Province, Argentina, W3400AMZ

Not Yet Recruiting

21

Tenax Investigational Site

San Luis, San Luis Province, Argentina, D5702JRS

Not Yet Recruiting

22

Tenax Investigational Site

Braunau am Inn, Austria, 5280

Not Yet Recruiting

23

Tenax Investigational Site

Graz, Austria, 8036

Not Yet Recruiting

24

Tenax Investigational Site

Klagenfurt, Austria, 9020

Not Yet Recruiting

25

Tenax Investigational Site

Sankt Pölten, Austria, 3100

Not Yet Recruiting

26

Tenax Investigational Site

Vienna, Austria, 1100

Not Yet Recruiting

27

Tenax Investigational Site

Salvador, Estado de Bahia, Brazil, 40170-130

Not Yet Recruiting

28

Tenax Investigational Site

Belo Horizonte, Minas Gerais, Brazil, 30220

Not Yet Recruiting

29

Tenax Investigational Site

Curitiba, Paraná, Brazil, 80215-901

Not Yet Recruiting

30

Tenax Investigational Site

Ribeirão Preto, São Paulo, Brazil, 14026-020

Not Yet Recruiting

31

Tenax Investigational Site

Pleven, Bulgaria, 5800

Not Yet Recruiting

32

Tenax Investigational Site

Sofia, Bulgaria, 1407

Not Yet Recruiting

33

Tenax Investigational Site

Sofia, Bulgaria, 1431

Not Yet Recruiting

34

Tenax Investigational Site

Sofia, Bulgaria, 1750

Not Yet Recruiting

35

Tenax Investigational Site

Ostrava, Czechia, 72880

Not Yet Recruiting

36

Tenax Investigational Site

Prague, Czechia, 10034

Not Yet Recruiting

37

Tenax Investigational Site

Prague, Czechia, 15006

Not Yet Recruiting

38

Tenax Investigational Site

Le Kremlin-Bicêtre, France, 94270

Not Yet Recruiting

39

Tenax Investigational Site

Montpellier, France, 34295

Not Yet Recruiting

40

Tenax Investigational Site

Nantes, France, 44007

Not Yet Recruiting

41

Tenax Investigational Site

Nice, France, 06001

Not Yet Recruiting

42

Tenax Investigational Site

Pau, France, 64000

Not Yet Recruiting

43

Tenax Investigational Site

Bad Bevensen, Germany, 29549

Not Yet Recruiting

44

Tenax Investigational Site

Bad Nauheim, Germany, 61231

Not Yet Recruiting

45

Tenax Investigational Site

Berlin, Germany, 12683

Not Yet Recruiting

46

Tenax Investigational Site

Dresden, Germany, 01307

Not Yet Recruiting

47

Tenax Investigational Site

Hamburg, Germany, 20251

Not Yet Recruiting

48

Tenax Investigational Site

Jena, Germany, 07747

Not Yet Recruiting

49

Tenax Investigational Site

Budapest, Hungary, 1122

Not Yet Recruiting

50

Tenax Investigational Site

Budapest, Hungary, 1134

Not Yet Recruiting

51

Tenax Investigational Site

Debrecen, Hungary, 4032

Not Yet Recruiting

52

Tenax Investigational Site

Szeged, Hungary, 6275

Not Yet Recruiting

53

Tenax Investigational Site

Acquaviva delle Fonti, Italy, 70021

Not Yet Recruiting

54

Tenax Investigational Site

Messina, Italy, 98125

Not Yet Recruiting

55

Tenax Investigational Site

Milan, Italy, 20132

Not Yet Recruiting

56

Tenax Investigational Site

Milan, Italy, 20138

Not Yet Recruiting

57

Tenax Investigational Site

Milan, Italy, 20149

Not Yet Recruiting

58

Tenax Investigational Site

Pavia, Italy, 27100

Not Yet Recruiting

59

Tenax Investigational Site

Pisa, Italy, 56126

Not Yet Recruiting

60

Tenax Investigational Site

Roma, Italy, 00168

Not Yet Recruiting

61

Tenax Investigational Site

Rozzano, Italy, 20089

Not Yet Recruiting

62

Tenax Investigational Site

Poznan, Poland, 61848

Not Yet Recruiting

63

Tenax Investigational Site

Wroclaw, Poland, 50556

Not Yet Recruiting

64

Tenax Investigational Site

Wroclaw, Poland, 50891

Not Yet Recruiting

65

Tenax Investigational Site

Cheongju-si, South Korea, 28644

Not Yet Recruiting

66

Tenax Investigational Site

Gwangju, South Korea, 61469

Not Yet Recruiting

67

Tenax Investigational Site

Incheon, South Korea, 21565

Not Yet Recruiting

68

Tenax Investigational Site

Seoul, South Korea, 03080

Not Yet Recruiting

69

Tenax Investigational Site

Seoul, South Korea, 08308

Not Yet Recruiting

70

Tenax Investigational Site

Wŏnju, South Korea, 26426

Not Yet Recruiting

71

Tenax Investigational Site

Barcelona, Spain, 08003

Not Yet Recruiting

72

Tenax Investigational Site

Barcelona, Spain, 08035

Not Yet Recruiting

73

Tenax Investigational Site

Barcelona, Spain, 08036

Not Yet Recruiting

74

Tenax Investigational Site

Lugo, Spain, 27003

Not Yet Recruiting

75

Tenax Investigational Site

Madrid, Spain, 28041

Not Yet Recruiting

76

Tenax Investigational Site

Madrid, Spain, 28046

Not Yet Recruiting

77

Tenax Investigational Site

Madrid, Spain, 28055

Not Yet Recruiting

78

Tenax Investigational Site

Marbella, Spain, 29603

Not Yet Recruiting

79

Tenax Investigational Site

Málaga, Spain, 29010

Not Yet Recruiting

80

Tenax Investigational Site

Pamplona, Spain, 31008

Not Yet Recruiting

81

Tenax Investigational Site

Salamanca, Spain, 37007

Not Yet Recruiting

82

Tenax Investigational Site

Seville, Spain, 41009

Not Yet Recruiting

83

Tenax Investigational Site

Toledo, Spain, 45007

Not Yet Recruiting

84

Tenax Investigational Site

Valencia, Spain, 46010

Not Yet Recruiting

85

Tenax Investigational Site

Valencia, Spain, 46020

Not Yet Recruiting

86

Tenax Investigational Site

Kaohsiung City, Taiwan, 80756

Not Yet Recruiting

87

Tenax Investigational Site

Kaohsiung City, Taiwan, 813414

Not Yet Recruiting

88

Tenax Investigational Site

Taipei, Taiwan, 10449

Not Yet Recruiting

89

Tenax Investigational Site

Taipei, Taiwan, 110

Not Yet Recruiting

90

Tenax Investigational Site

Taoyuan, Taiwan, 33305

Not Yet Recruiting

91

Tenax Investigational Site

Cambridge, United Kingdom, CB233RE

Not Yet Recruiting

92

Tenax Investigational Site

Swindon, United Kingdom, SN36BB

Not Yet Recruiting

Loading map...

Research Team

A

Akshata Ashokkumar

CONTACT

K

Katelyn Jansson

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here